Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms
about
Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Peripartum depression and anxiety as an integrative cross domain target for psychiatric preventative measuresAutism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive TherapyThe serotonin system in autism spectrum disorder: From biomarker to animal modelsEarly involvement in friendships predicts later plasma concentrations of oxytocin and vasopressin in juvenile rhesus macaques (Macaca mulatta)Species, sex and individual differences in the vasotocin/vasopressin system: relationship to neurochemical signaling in the social behavior neural network.Vasopressin Proves Es-sense-tial: Vasopressin and the Modulation of Sensory Processing in Mammals.Serum Oxytocin Levels and an Oxytocin Receptor Gene Polymorphism (rs2254298) Indicate Social Deficits in Children and Adolescents with Autism Spectrum DisordersTransgenerational effects of social stress on social behavior, corticosterone, oxytocin, and prolactin in rats.The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: A hypothesis paperEarly Intranasal Vasopressin Administration Impairs Partner Preference in Adult Male Prairie Voles (Microtus ochrogaster).Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.Oxytocin treatment in pediatric populationsOxytocin and vasopressin receptor polymorphisms interact with circulating neuropeptides to predict human emotional reactions to stress.Oxytocin plasma concentrations in children and adolescents with autism spectrum disorder: correlation with autistic symptomatology.Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disordersAssessing the impact of copy number variants on miRNA genes in autism by Monte Carlo simulation.Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behaviorPlasma Oxytocin in Children with Autism and Its Correlations with Behavioral Parameters in Children and Parents.Variants in Adjacent Oxytocin/Vasopressin Gene Region and Associations with ASD Diagnosis and Other Autism Related Endophenotypes.Comparing oxytocin and cortisol regulation in a double-blind, placebo-controlled, hydrocortisone challenge pilot study in children with autism and typical development.The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.Effects of Chronic Social Stress and Maternal Intranasal Oxytocin and Vasopressin on Offspring Interferon-γ and Behavior.Is oxytocin a maternal-foetal signalling molecule at birth? Implications for development.The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder.Developmental neurogenetics and multimodal neuroimaging of sex differences in autism.Reliability of basal plasma vasopressin concentrations in healthy male adults.Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.Gestational Age at Term, Delivery Circumstance, and Their Association with Childhood Attention Deficit Hyperactivity Disorder Symptoms.Anxiety Levels in Children with Autism Spectrum Disorder: A Meta-Analysis.Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.Plasma Oxytocin and Arginine-Vasopressin Levels in Children with Autism Spectrum Disorder in China: Associations with Symptoms.[Oxytocin: evidence for a therapeutic potential of the social neuromodulator].Early life social stress and resting state functional connectivity in postpartum rat anterior cingulate circuits.Biomarker discovery for disease status and symptom severity in children with autism.Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder.
P2860
Q26741618-2F04CB59-1CCD-4E8A-9072-9134F7E28BDAQ27015195-660F252F-05E6-428E-8A49-620CA49EAA0BQ27336849-892DCB65-2AB8-4C43-A28F-48F96F922876Q28391614-D265E34D-DF99-43B5-8722-0D82A38CDFA3Q28656405-285DC4CA-1A6A-4263-ABDC-5DBA4CC3D10FQ30394718-921EF3A4-E6BA-44D5-996E-F480A7224DD0Q30418389-7899D95E-72FD-48FD-A770-7CA977CA41FFQ33586158-FD13BAA9-B589-414E-9A9F-6F188227F4AEQ33828138-75D31F42-9F33-4DA9-BF19-9D61AC095871Q33835785-0BCF77C3-2F8C-4A9A-9544-CE5516990488Q33843159-49CD6BE9-E56E-4BC2-A256-3DD4D9E31839Q34082833-08411241-7EAD-4E5F-A17D-6C8C1713A318Q34349468-4715C45B-C38E-4D33-A1D3-E9C71102C2D8Q34409254-35D51972-D16F-4CA7-BF2D-FB40BC8B5EBBQ34427603-7F959F9F-CBB5-4DE9-87F3-77308D84C9BDQ34486374-2D81433C-7B2D-4386-A1EC-703FC7FBA9C1Q34654354-412DB165-889F-4652-AEFB-1C5C72915779Q35009426-CABE9F94-7565-482A-8F95-46C60DC7C0C8Q35130993-1948C4AE-7FA2-4834-9C0C-38F71BC1A341Q36249172-9A2753C2-E64D-471D-BFB3-6F1A27A520F8Q36772468-1FB5507E-4112-4B62-80B4-F283B3FEE9C8Q36892246-B4558424-C0E6-4FF0-BCC1-C9536942882BQ37185279-D69271EF-40C2-43DA-860C-099FBD129656Q37367588-9235C79A-1485-453B-96A3-28F1C3DA8C1EQ37500594-0034D62B-4E28-4E2D-A058-2E297C8DA527Q38233628-3F068955-BA6A-4979-9A4B-8F56B5E4B8DFQ38678068-E1194F08-A18D-4A37-9819-ADD8EE769619Q38701771-26D475E3-1A5F-4456-B69E-95378CBF00F5Q38786523-26D6C1DD-F226-4965-AB34-586CF4C1A062Q38960225-A6863CBA-38D3-4FFF-9548-3A5AB1DA0A74Q40134803-2528928D-4443-4506-93F2-05AF7E6FE158Q41022694-784837F3-4ED5-4EEA-BECE-8794B2DF33D1Q41256682-B068B454-690C-47AD-A3B9-F659A5AD0B20Q41655010-06619DF2-C3DA-41A7-A5D8-41164B078236Q45359037-3B1E06F4-ADD8-4058-9887-28E957FFBCDDQ47555003-156F2270-F2BB-46E6-8D7A-B33745DDA2E2Q47563967-994ACEAA-97CC-4C79-9E47-0D01B49169C8Q47779144-AE1EF3C5-1C00-48FE-B93B-1F8D9C222BA9Q50204431-57DA2162-5F37-45BA-B0C1-D4F9E7072221Q50301146-4D7FCEC4-C61A-42BE-B9AA-8D78F4FFF3B9
P2860
Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Oxytocin and vasopressin in ch ...... and associations with symptoms
@en
type
label
Oxytocin and vasopressin in ch ...... and associations with symptoms
@en
prefLabel
Oxytocin and vasopressin in ch ...... and associations with symptoms
@en
P2093
P2860
P921
P356
P1433
P1476
Oxytocin and vasopressin in ch ...... and associations with symptoms
@en
P2093
Cameron S Carter
Caroline M Hostetler
Karen L Bales
Marjorie Solomon
P2860
P304
P356
10.1002/AUR.1270
P577
2013-02-14T00:00:00Z